RadNet Inc. (NASDAQ:RDNT) insider Norman R. Hames sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $9.87, for a total value of $98,700.00. Following the completion of the sale, the insider now owns 380,087 shares in the company, valued at $3,751,458.69. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

RadNet Inc. (NASDAQ:RDNT) traded down $0.20 during mid-day trading on Thursday, hitting $9.70. The stock had a trading volume of 215,122 shares, compared to its average volume of 206,697. RadNet Inc. has a 52 week low of $5.25 and a 52 week high of $11.90. The company has a market cap of $469.10, a price-to-earnings ratio of 32.83, a P/E/G ratio of 3.31 and a beta of 0.82. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29.

RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, meeting the consensus estimate of $0.12. The company had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The company’s revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.11 EPS. research analysts expect that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.

Several equities research analysts have recently weighed in on RDNT shares. Jefferies Group upgraded RadNet from a “hold” rating to a “buy” rating and upped their price objective for the company from $7.00 to $12.00 in a research note on Tuesday, August 22nd. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th. TheStreet upgraded RadNet from a “c” rating to a “b-” rating in a research note on Thursday, August 24th. Finally, Zacks Investment Research lowered RadNet from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wells Fargo & Company MN boosted its holdings in shares of RadNet by 1.9% in the 2nd quarter. Wells Fargo & Company MN now owns 35,843 shares of the medical research company’s stock worth $278,000 after acquiring an additional 654 shares in the last quarter. Bank of America Corp DE boosted its holdings in shares of RadNet by 5.9% in the 1st quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock worth $157,000 after acquiring an additional 1,477 shares in the last quarter. National Planning Corp boosted its holdings in shares of RadNet by 9.8% in the 2nd quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock worth $132,000 after acquiring an additional 1,500 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of RadNet by 6.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 33,305 shares of the medical research company’s stock worth $258,000 after acquiring an additional 1,997 shares in the last quarter. Finally, Citigroup Inc. boosted its holdings in shares of RadNet by 3.5% in the 2nd quarter. Citigroup Inc. now owns 66,202 shares of the medical research company’s stock worth $513,000 after acquiring an additional 2,245 shares in the last quarter. 53.24% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Insider Selling: RadNet Inc. (RDNT) Insider Sells 10,000 Shares of Stock” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/12/14/insider-selling-radnet-inc-rdnt-insider-sells-10000-shares-of-stock.html.

About RadNet

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.